Aorta Infrarenal Stenosis: BE, SE or Covered Stents? CRT 2012

Slides:



Advertisements
Similar presentations
Arterial Fibrodysplasia
Advertisements

DEFINITIVE AR - Acute Outcomes -
Andrew Bunney MD, PGY-4 University of Minnesota
Presented by Lori Dafoe, CPC.  CPT Chapter Notes CPT Assistant Articles  Laminated, color coded vascular charts Medlearn/Panacea Medical Asset Management.
Viabahn Covered Stents for Cephalic Arch Stenosis Can Improve Patency and Longevity of Upper Arm AV Fistulas Toufic Safa, MD, FACS Vascular & Endovascular.
When the blood vessels become obstructed, the tissues do not receive the necessary circulation to thrive. Over time, the area may become.
Superficial Femoral Artery Stents - Bare, Covered, or Drug-Coated – “The Data and The HYPE” Dennis F. Bandyk, MD Division of Vascular & Endovascular Surgery.
A Metanalysis on the Long Term Outcomes Comparing Endovascular Repair Versus Open Repair of an Abdominal Aortic Aneurysm JOSHUA M. CAMOMOT, M.D. Perpetual.
Biondi-Zoccai: Peripheral interventions – metcardio.org Basic principles of peripheral interventions Giuseppe Biondi Zoccai University.
VIABAHN Endoprosthesis for Severe Femoropopliteal Lesions 舒 畅 Dept. of Vascular Surgery, The 2nd Xiang-Ya Hospital, Central-South University 中南大学湘雅二医院血管外科.
Klinikum Rosenheim Department of Diagnostic and Interventional Radiology LINC 2014 DEFINITIVE AR Severe Ca++ Arm 30-Day Results Gunnar Tepe, MD On behalf.
Is There Still a Controversy About Stent Type for TASC C&D Lesions
Confidential: Internal Use only 1 Click to edit Master title style Click to edit Master text styles – Second level Third level – Fourth level » Fifth level.
Intervention of Aortic Coarctation: from Angioplasty to Stent
经桡肾动脉支架术 Transradial Approach in Renal Stenting Jianfang Luo 罗建方 Guangdong General Hospital.
Vertebral PTA: Indications and Technique Patrick L. Whitlow, MD Director, Interventional Cardiology The Cleveland Clinic Foundation Patrick L. Whitlow,
Peripheral Interventions: Unmet needs!
FMRP 2014 | 1 Marc Bosiers Koen Deloose Joren Callaert A.Z. Sint-Blasius, Dendermonde Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist OLV Hospital,
Interventional Treatment of obstructive aortoiliac disease Dr Afshin Ghofraniha Interventional Cardiologist.
Antegrade Femoral Artery Access
Novel Trial Design Focus - Left Main and “All Comers” DES Studies: All-Comers Studies. Interventional View Jeffrey J. Popma, MD Director, Innovations in.
CRT 2012 Venous Disease.
The Missing Bifurcation
Iliac and Aortiliac Occlusions: Stent Grafts or Bare Metal Stents…
Management of Patients on Chronic Oral Anticoagulant Therapy
New Stent Designs Applicable for Renal Intervention
OCT GUIDANCE FOR CTO AVINGER
Rajesh Dave, MD, FACC, FSCAI Harrisburg, PA
Direct access of the SFA: step by step
Heavily calcified SFA lesions do not avoid the use of 4 F systems
Complex Ostial Disease of the Aortic Arch Vessels
James P. Zidar, M.D., F.A.C.C., F.S.C.A.I
Stent Graft for the Treatment of ISR:
(DES)+BVS +DCB for long diffuse LAD disease
How to Handle a Complex Bifurcation Lesion
EVAR Planning: Keys to Success
Endurant: A New Generation Endograft
Angiographic Features of Atherosclerotic Superficial Femoral Artery Disease in Diabetics and Non-diabetics Presenting with Claudication Atif Mohammad,
Carotid Artery Stenting Predictors of procedural and clinical success
CRT Washington, D.C. February 23, 2010 Tim A. Fischell, M.D. FACC
Restenosis in Peripheral Arteries
TAVI „Catch me if you can!“
Crossing SFA-Popliteal Artery CTO’s
Columbia University College of Physicians and Surgeons
Renal CTA: Can We Determine Who Will Benefit from RAS
How to do endovascular mechanical thrombaspiration
The Tryton Bifurcation Trial:
Subintimal Tracking and Reentry for CTO STAR Method
Medical Director of the Vascular Center
Instent Restenosis and Occlusion: Time for Surgical Revision?
Recanilization of Central Venous Total Occlusions
Percutaneous Reconstruction of the Aortoiliac Bifurcation
Essesntials for CTO Recanalization
Are we using fewer Covered Stents for SFA Occlusive Disease?
James P. Zidar, M.D., F.A.C.C., F.S.C.A.I
Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament  Keith D. Calligaro, MD, Praveen Balraj, MD, Neil Moudgill, MD,
Outcomes of a novel technique of endovascular repair of aneurysmal internal iliac arteries using iliac branch devices  Martin Austermann, MD, Theodosios.
Stent graft modification with mini-cuff reinforced fenestrations for urgent repair of thoracoabdominal aortic aneurysms  Gustavo S. Oderich, MD, Javairiah.
Endovascular repair of thoracoabdominal aortic aneurysm using the off-the-shelf multibranched t-Branch stent graft  Bernardo C. Mendes, MD, Gustavo S.
Preliminary clinical outcome and imaging criterion for endovascular prosthesis development in high-risk patients who have aortoiliac and traumatic arterial.
Endovascular treatment of TransAtlantic Inter-Society Consensus D aortoiliac occlusive disease using unibody bifurcated endografts  Robert M. Van Haren,
Arne Gerhard Schwindt, MD, Giuseppe Panuccio, MD, Konstantinos P
Technical aspects of repair of juxtarenal abdominal aortic aneurysms using the Zenith fenestrated endovascular stent graft  Gustavo S. Oderich, MD, Mateus.
Division of Endovascular Interventions
Endovascular Live Case Mount Sinai Hospital, NY
Endovascular aneurysm repair for ruptured abdominal aortic aneurysm: The Albany Vascular Group approach  Manish Mehta, MD, MPH  Journal of Vascular Surgery 
Endovascular treatment of thoracoabdominal aortic aneurysms
University of Florida, Gainesville
Patient history 71 year old female patient, presents with LLE claudication (buttock, thigh and calf). Rutherford class 3 PMH: active smoker, HTN and HLD.
Peripheral Vascular Intervention
Presentation transcript:

Aorta Infrarenal Stenosis: BE, SE or Covered Stents? CRT 2012 Rajesh M. Dave, MD, FACC, FSCAI Chief Medical Executive, Cardiovascular Institute at Ortenzio Heart center, Holy Spirit Hospital Chief, Department of Cardiology Chairman, Cardiac Catheterization Laboratory Camp Hill, PA

Rajesh M. Dave, MD Honoraria Abbott Laboratories Atrium Medical Corporation Cardiovascular Systems Inc. Daiichi Sankyo Bard Peripheral Vascular, Inc. Pathway Medical Technologies, Inc. Abiomed, Inc. Ev3, Inc.

Infrarenal Aortic Lesions: ?PTA Vs Stent PTA feasible: Restenosis in 30% of patients at 5 years 1 Limitations of PTA: risk of distal embolization, embolization of debris, Perforation, Underexpansion of lesions and recoil Stents? Lower Restenosis , Less Recoil Covered2 vs Bare, BE vs SE Cardiovasc Interven Radiol 1989 12:1-6 2. J Vasc Surg. 2011 Dec; 54(6) :1561-70.

Covered Vs Bare: general considerations Covered Advantage: Protection against Perforation and embolization, two most critical complications Covered Disadvantage: Limited size availability in USA (e.g. I-Cast, Fluency, Viabahn, Aortic Cuffs) Bare Stents, Advantages: Many choices, generally smaller sheath sizes Bare disadvantage- Tissue proliferation-higher restenosis rates, especially in TASC C and D Lesions (shown in iliac lesions)

Covered Stents: Access Size and general considerations, Know your choices Icast ( BE Covered): ( Under FDA review for On Label Iliac Indication) -7F sheath compatible ( 10mm can be postdilated to 12mm) -12mm stent 9F sheath ( 12mm stent can be expanded to 22mm) ( Not available in USA, investigational) Fluency(SE covered): (Tracheobronchial indication) Max 10mm diameter -Above 7mmx80mm stent requires 9F or above sheath, can go bareback Viabahn (Iliac Indication, SE Covered): largest 13mm diameter, needs larger than 12F sheath Wallstent Graft; ( SE Covered) ( Billiary): max size

Infrarenal Aortic Lesion : Considerations prior to treatment With or Without Iliac Involvement Calcification: Degree Aneurysmal Vs Non Aneurysmal Disease Ulcerations Total Occlusion- Level Size of Aorta: limited stent sizes in certain cases in USA Relationship to surrounding vessels ie. Renals, Important collaterals etc. Tolerability for access sheath size Availability of IVUS, CTA, MRA

84 yof Severe Claudication and Trash Feet

IVUS is almost Mandatory In my lab, CTA Eccentricity, Calcification

PTA 12mmX 30mm 9mmX59mm ICast

Postdilation by 14mm NC balloon

OUS Case: V12, Large Aorta of 16mm size V12 stent not available for use in USA, investigational device in USA

Aortoiliac Involvement

Problem with Crossing Bilateral Iliac Bare Stents: Avoid!!!

Icast 8mm X 59mm Bilaterally

Conclusions No Randomized trial exists between different stent types Covered stents have significant advantage of Protection against Embolization, Perforation Covered stent: Lower Restenosis Covered BE: Precise Placement, small access sheath sizes, Limitation in current sizes

Conclusions Covered SE: Larger sheath size or open access but larger size available in certain brands BE Bare: Excellent choice for focal non calcified and non thrombotic lesion SE Bare: Easy deployment, large sizes available up to 14mm Bare Disadvantage? Higher restenosis, Higher embolization, perforation

My Personal Strategy Associated aneurysm larger than 4cm or deep penetrating ulcers consider full endograft Smaller than 14mm Aorta BE Covered is my first choice, In future if 12mms BE covered becomes available it will increase options, IVUS is MUST Larger than 14mm aorta, mostly use Endograft Cuffs

Thank you